The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Diagnostic Kits Market Research Report 2024
Synopsis
The global Molecular Diagnostic Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global molecular diagnostic kits market is expected to witness significant growth due to increasing disease prevalence, advancements in personalized medicine, and technological innovations. Continued research and development, collaborations between industry stakeholders and healthcare providers, addressing reimbursement challenges, and improving accessibility in under-served regions will drive market expansion and enable molecular diagnostic kits to contribute to more accurate and personalized patient care.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Kits.
Report Scope
The Molecular Diagnostic Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Hologic
Grifols
BioMérieux
Qiagen
Abbott
Thermo Fisher
Bio-Rad
Illumina
Siemens
Agilent
Daangene
Diasorin
Merck
KHB
liferiver
Leadman
Triplex
BGI
Segment by Type
PCR
Gene Chip
Fluorescence in Situ Hybridization
DNA Sequencing
Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostic Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostic Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Molecular Diagnostic Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global molecular diagnostic kits market is expected to witness significant growth due to increasing disease prevalence, advancements in personalized medicine, and technological innovations. Continued research and development, collaborations between industry stakeholders and healthcare providers, addressing reimbursement challenges, and improving accessibility in under-served regions will drive market expansion and enable molecular diagnostic kits to contribute to more accurate and personalized patient care.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Kits.
Report Scope
The Molecular Diagnostic Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostic Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostic Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Hologic
Grifols
BioMérieux
Qiagen
Abbott
Thermo Fisher
Bio-Rad
Illumina
Siemens
Agilent
Daangene
Diasorin
Merck
KHB
liferiver
Leadman
Triplex
BGI
Segment by Type
PCR
Gene Chip
Fluorescence in Situ Hybridization
DNA Sequencing
Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Molecular Diagnostic Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Molecular Diagnostic Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Molecular Diagnostic Kits Market Overview
1.1 Product Overview and Scope of Molecular Diagnostic Kits
1.2 Molecular Diagnostic Kits Segment by Type
1.2.1 Global Molecular Diagnostic Kits Market Value Comparison by Type (2024-2030)
1.2.2 PCR
1.2.3 Gene Chip
1.2.4 Fluorescence in Situ Hybridization
1.2.5 DNA Sequencing
1.3 Molecular Diagnostic Kits Segment by Application
1.3.1 Global Molecular Diagnostic Kits Market Value by Application: (2024-2030)
1.3.2 Infectious Disease Diagnosis
1.3.3 Genetic Diagnosis
1.3.4 Blood Screening
1.3.5 Other
1.4 Global Molecular Diagnostic Kits Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostic Kits Revenue 2019-2030
1.4.2 Global Molecular Diagnostic Kits Sales 2019-2030
1.4.3 Global Molecular Diagnostic Kits Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Molecular Diagnostic Kits Market Competition by Manufacturers
2.1 Global Molecular Diagnostic Kits Sales Market Share by Manufacturers (2019-2024)
2.2 Global Molecular Diagnostic Kits Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Molecular Diagnostic Kits Average Price by Manufacturers (2019-2024)
2.4 Global Molecular Diagnostic Kits Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Molecular Diagnostic Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Molecular Diagnostic Kits, Product Type & Application
2.7 Molecular Diagnostic Kits Market Competitive Situation and Trends
2.7.1 Molecular Diagnostic Kits Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Molecular Diagnostic Kits Players Market Share by Revenue
2.7.3 Global Molecular Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Diagnostic Kits Retrospective Market Scenario by Region
3.1 Global Molecular Diagnostic Kits Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Molecular Diagnostic Kits Global Molecular Diagnostic Kits Sales by Region: 2019-2030
3.2.1 Global Molecular Diagnostic Kits Sales by Region: 2019-2024
3.2.2 Global Molecular Diagnostic Kits Sales by Region: 2025-2030
3.3 Global Molecular Diagnostic Kits Global Molecular Diagnostic Kits Revenue by Region: 2019-2030
3.3.1 Global Molecular Diagnostic Kits Revenue by Region: 2019-2024
3.3.2 Global Molecular Diagnostic Kits Revenue by Region: 2025-2030
3.4 North America Molecular Diagnostic Kits Market Facts & Figures by Country
3.4.1 North America Molecular Diagnostic Kits Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Molecular Diagnostic Kits Sales by Country (2019-2030)
3.4.3 North America Molecular Diagnostic Kits Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Molecular Diagnostic Kits Market Facts & Figures by Country
3.5.1 Europe Molecular Diagnostic Kits Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Molecular Diagnostic Kits Sales by Country (2019-2030)
3.5.3 Europe Molecular Diagnostic Kits Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Molecular Diagnostic Kits Market Facts & Figures by Country
3.6.1 Asia Pacific Molecular Diagnostic Kits Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Molecular Diagnostic Kits Sales by Country (2019-2030)
3.6.3 Asia Pacific Molecular Diagnostic Kits Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Molecular Diagnostic Kits Market Facts & Figures by Country
3.7.1 Latin America Molecular Diagnostic Kits Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Molecular Diagnostic Kits Sales by Country (2019-2030)
3.7.3 Latin America Molecular Diagnostic Kits Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Molecular Diagnostic Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Molecular Diagnostic Kits Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Molecular Diagnostic Kits Sales by Country (2019-2030)
3.8.3 Middle East and Africa Molecular Diagnostic Kits Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Molecular Diagnostic Kits Sales by Type (2019-2030)
4.1.1 Global Molecular Diagnostic Kits Sales by Type (2019-2024)
4.1.2 Global Molecular Diagnostic Kits Sales by Type (2025-2030)
4.1.3 Global Molecular Diagnostic Kits Sales Market Share by Type (2019-2030)
4.2 Global Molecular Diagnostic Kits Revenue by Type (2019-2030)
4.2.1 Global Molecular Diagnostic Kits Revenue by Type (2019-2024)
4.2.2 Global Molecular Diagnostic Kits Revenue by Type (2025-2030)
4.2.3 Global Molecular Diagnostic Kits Revenue Market Share by Type (2019-2030)
4.3 Global Molecular Diagnostic Kits Price by Type (2019-2030)
5 Segment by Application
5.1 Global Molecular Diagnostic Kits Sales by Application (2019-2030)
5.1.1 Global Molecular Diagnostic Kits Sales by Application (2019-2024)
5.1.2 Global Molecular Diagnostic Kits Sales by Application (2025-2030)
5.1.3 Global Molecular Diagnostic Kits Sales Market Share by Application (2019-2030)
5.2 Global Molecular Diagnostic Kits Revenue by Application (2019-2030)
5.2.1 Global Molecular Diagnostic Kits Revenue by Application (2019-2024)
5.2.2 Global Molecular Diagnostic Kits Revenue by Application (2025-2030)
5.2.3 Global Molecular Diagnostic Kits Revenue Market Share by Application (2019-2030)
5.3 Global Molecular Diagnostic Kits Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Molecular Diagnostic Kits Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Danaher Molecular Diagnostic Kits Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Hologic
6.3.1 Hologic Corporation Information
6.3.2 Hologic Description and Business Overview
6.3.3 Hologic Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hologic Molecular Diagnostic Kits Product Portfolio
6.3.5 Hologic Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Molecular Diagnostic Kits Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 BioMérieux
6.5.1 BioMérieux Corporation Information
6.5.2 BioMérieux Description and Business Overview
6.5.3 BioMérieux Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioMérieux Molecular Diagnostic Kits Product Portfolio
6.5.5 BioMérieux Recent Developments/Updates
6.6 Qiagen
6.6.1 Qiagen Corporation Information
6.6.2 Qiagen Description and Business Overview
6.6.3 Qiagen Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qiagen Molecular Diagnostic Kits Product Portfolio
6.6.5 Qiagen Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Molecular Diagnostic Kits Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Thermo Fisher
6.8.1 Thermo Fisher Corporation Information
6.8.2 Thermo Fisher Description and Business Overview
6.8.3 Thermo Fisher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fisher Molecular Diagnostic Kits Product Portfolio
6.8.5 Thermo Fisher Recent Developments/Updates
6.9 Bio-Rad
6.9.1 Bio-Rad Corporation Information
6.9.2 Bio-Rad Description and Business Overview
6.9.3 Bio-Rad Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bio-Rad Molecular Diagnostic Kits Product Portfolio
6.9.5 Bio-Rad Recent Developments/Updates
6.10 Illumina
6.10.1 Illumina Corporation Information
6.10.2 Illumina Description and Business Overview
6.10.3 Illumina Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Illumina Molecular Diagnostic Kits Product Portfolio
6.10.5 Illumina Recent Developments/Updates
6.11 Siemens
6.11.1 Siemens Corporation Information
6.11.2 Siemens Molecular Diagnostic Kits Description and Business Overview
6.11.3 Siemens Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Siemens Molecular Diagnostic Kits Product Portfolio
6.11.5 Siemens Recent Developments/Updates
6.12 Agilent
6.12.1 Agilent Corporation Information
6.12.2 Agilent Molecular Diagnostic Kits Description and Business Overview
6.12.3 Agilent Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Agilent Molecular Diagnostic Kits Product Portfolio
6.12.5 Agilent Recent Developments/Updates
6.13 Daangene
6.13.1 Daangene Corporation Information
6.13.2 Daangene Molecular Diagnostic Kits Description and Business Overview
6.13.3 Daangene Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Daangene Molecular Diagnostic Kits Product Portfolio
6.13.5 Daangene Recent Developments/Updates
6.14 Diasorin
6.14.1 Diasorin Corporation Information
6.14.2 Diasorin Molecular Diagnostic Kits Description and Business Overview
6.14.3 Diasorin Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Diasorin Molecular Diagnostic Kits Product Portfolio
6.14.5 Diasorin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Molecular Diagnostic Kits Description and Business Overview
6.15.3 Merck Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Merck Molecular Diagnostic Kits Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 KHB
6.16.1 KHB Corporation Information
6.16.2 KHB Molecular Diagnostic Kits Description and Business Overview
6.16.3 KHB Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.16.4 KHB Molecular Diagnostic Kits Product Portfolio
6.16.5 KHB Recent Developments/Updates
6.17 liferiver
6.17.1 liferiver Corporation Information
6.17.2 liferiver Molecular Diagnostic Kits Description and Business Overview
6.17.3 liferiver Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.17.4 liferiver Molecular Diagnostic Kits Product Portfolio
6.17.5 liferiver Recent Developments/Updates
6.18 Leadman
6.18.1 Leadman Corporation Information
6.18.2 Leadman Molecular Diagnostic Kits Description and Business Overview
6.18.3 Leadman Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Leadman Molecular Diagnostic Kits Product Portfolio
6.18.5 Leadman Recent Developments/Updates
6.19 Triplex
6.19.1 Triplex Corporation Information
6.19.2 Triplex Molecular Diagnostic Kits Description and Business Overview
6.19.3 Triplex Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Triplex Molecular Diagnostic Kits Product Portfolio
6.19.5 Triplex Recent Developments/Updates
6.20 BGI
6.20.1 BGI Corporation Information
6.20.2 BGI Molecular Diagnostic Kits Description and Business Overview
6.20.3 BGI Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2019-2024)
6.20.4 BGI Molecular Diagnostic Kits Product Portfolio
6.20.5 BGI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Molecular Diagnostic Kits Industry Chain Analysis
7.2 Molecular Diagnostic Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Molecular Diagnostic Kits Production Mode & Process
7.4 Molecular Diagnostic Kits Sales and Marketing
7.4.1 Molecular Diagnostic Kits Sales Channels
7.4.2 Molecular Diagnostic Kits Distributors
7.5 Molecular Diagnostic Kits Customers
8 Molecular Diagnostic Kits Market Dynamics
8.1 Molecular Diagnostic Kits Industry Trends
8.2 Molecular Diagnostic Kits Market Drivers
8.3 Molecular Diagnostic Kits Market Challenges
8.4 Molecular Diagnostic Kits Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Molecular Diagnostic Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Molecular Diagnostic Kits Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Molecular Diagnostic Kits Market Competitive Situation by Manufacturers in 2023
Table 4. Global Molecular Diagnostic Kits Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Molecular Diagnostic Kits Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Molecular Diagnostic Kits Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Molecular Diagnostic Kits Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Molecular Diagnostic Kits Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Molecular Diagnostic Kits, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Diagnostic Kits, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Diagnostic Kits, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Diagnostic Kits, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Diagnostic Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Kits as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Diagnostic Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Molecular Diagnostic Kits Sales by Region (2019-2024) & (K Units)
Table 18. Global Molecular Diagnostic Kits Sales Market Share by Region (2019-2024)
Table 19. Global Molecular Diagnostic Kits Sales by Region (2025-2030) & (K Units)
Table 20. Global Molecular Diagnostic Kits Sales Market Share by Region (2025-2030)
Table 21. Global Molecular Diagnostic Kits Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Molecular Diagnostic Kits Revenue Market Share by Region (2019-2024)
Table 23. Global Molecular Diagnostic Kits Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Molecular Diagnostic Kits Revenue Market Share by Region (2025-2030)
Table 25. North America Molecular Diagnostic Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Molecular Diagnostic Kits Sales by Country (2019-2024) & (K Units)
Table 27. North America Molecular Diagnostic Kits Sales by Country (2025-2030) & (K Units)
Table 28. North America Molecular Diagnostic Kits Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Molecular Diagnostic Kits Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Molecular Diagnostic Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Molecular Diagnostic Kits Sales by Country (2019-2024) & (K Units)
Table 32. Europe Molecular Diagnostic Kits Sales by Country (2025-2030) & (K Units)
Table 33. Europe Molecular Diagnostic Kits Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Molecular Diagnostic Kits Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Molecular Diagnostic Kits Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Molecular Diagnostic Kits Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Molecular Diagnostic Kits Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Molecular Diagnostic Kits Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Molecular Diagnostic Kits Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Molecular Diagnostic Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Molecular Diagnostic Kits Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Molecular Diagnostic Kits Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Molecular Diagnostic Kits Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Molecular Diagnostic Kits Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostic Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Molecular Diagnostic Kits Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Molecular Diagnostic Kits Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Molecular Diagnostic Kits Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Molecular Diagnostic Kits Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Molecular Diagnostic Kits Sales (K Units) by Type (2019-2024)
Table 51. Global Molecular Diagnostic Kits Sales (K Units) by Type (2025-2030)
Table 52. Global Molecular Diagnostic Kits Sales Market Share by Type (2019-2024)
Table 53. Global Molecular Diagnostic Kits Sales Market Share by Type (2025-2030)
Table 54. Global Molecular Diagnostic Kits Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Molecular Diagnostic Kits Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Molecular Diagnostic Kits Revenue Market Share by Type (2019-2024)
Table 57. Global Molecular Diagnostic Kits Revenue Market Share by Type (2025-2030)
Table 58. Global Molecular Diagnostic Kits Price (US$/Unit) by Type (2019-2024)
Table 59. Global Molecular Diagnostic Kits Price (US$/Unit) by Type (2025-2030)
Table 60. Global Molecular Diagnostic Kits Sales (K Units) by Application (2019-2024)
Table 61. Global Molecular Diagnostic Kits Sales (K Units) by Application (2025-2030)
Table 62. Global Molecular Diagnostic Kits Sales Market Share by Application (2019-2024)
Table 63. Global Molecular Diagnostic Kits Sales Market Share by Application (2025-2030)
Table 64. Global Molecular Diagnostic Kits Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Molecular Diagnostic Kits Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Molecular Diagnostic Kits Revenue Market Share by Application (2019-2024)
Table 67. Global Molecular Diagnostic Kits Revenue Market Share by Application (2025-2030)
Table 68. Global Molecular Diagnostic Kits Price (US$/Unit) by Application (2019-2024)
Table 69. Global Molecular Diagnostic Kits Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Molecular Diagnostic Kits Product
Table 74. Roche Recent Developments/Updates
Table 75. Danaher Corporation Information
Table 76. Danaher Description and Business Overview
Table 77. Danaher Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Danaher Molecular Diagnostic Kits Product
Table 79. Danaher Recent Developments/Updates
Table 80. Hologic Corporation Information
Table 81. Hologic Description and Business Overview
Table 82. Hologic Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Hologic Molecular Diagnostic Kits Product
Table 84. Hologic Recent Developments/Updates
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Grifols Molecular Diagnostic Kits Product
Table 89. Grifols Recent Developments/Updates
Table 90. BioMérieux Corporation Information
Table 91. BioMérieux Description and Business Overview
Table 92. BioMérieux Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioMérieux Molecular Diagnostic Kits Product
Table 94. BioMérieux Recent Developments/Updates
Table 95. Qiagen Corporation Information
Table 96. Qiagen Description and Business Overview
Table 97. Qiagen Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Qiagen Molecular Diagnostic Kits Product
Table 99. Qiagen Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Abbott Molecular Diagnostic Kits Product
Table 104. Abbott Recent Developments/Updates
Table 105. Thermo Fisher Corporation Information
Table 106. Thermo Fisher Description and Business Overview
Table 107. Thermo Fisher Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Thermo Fisher Molecular Diagnostic Kits Product
Table 109. Thermo Fisher Recent Developments/Updates
Table 110. Bio-Rad Corporation Information
Table 111. Bio-Rad Description and Business Overview
Table 112. Bio-Rad Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Bio-Rad Molecular Diagnostic Kits Product
Table 114. Bio-Rad Recent Developments/Updates
Table 115. Illumina Corporation Information
Table 116. Illumina Description and Business Overview
Table 117. Illumina Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Illumina Molecular Diagnostic Kits Product
Table 119. Illumina Recent Developments/Updates
Table 120. Siemens Corporation Information
Table 121. Siemens Description and Business Overview
Table 122. Siemens Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Siemens Molecular Diagnostic Kits Product
Table 124. Siemens Recent Developments/Updates
Table 125. Agilent Corporation Information
Table 126. Agilent Description and Business Overview
Table 127. Agilent Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Agilent Molecular Diagnostic Kits Product
Table 129. Agilent Recent Developments/Updates
Table 130. Daangene Corporation Information
Table 131. Daangene Description and Business Overview
Table 132. Daangene Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Daangene Molecular Diagnostic Kits Product
Table 134. Daangene Recent Developments/Updates
Table 135. Diasorin Corporation Information
Table 136. Diasorin Description and Business Overview
Table 137. Diasorin Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Diasorin Molecular Diagnostic Kits Product
Table 139. Diasorin Recent Developments/Updates
Table 140. Merck Corporation Information
Table 141. Merck Description and Business Overview
Table 142. Merck Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Merck Molecular Diagnostic Kits Product
Table 144. Merck Recent Developments/Updates
Table 145. KHB Corporation Information
Table 146. KHB Description and Business Overview
Table 147. KHB Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. KHB Molecular Diagnostic Kits Product
Table 149. KHB Recent Developments/Updates
Table 150. liferiver Corporation Information
Table 151. liferiver Description and Business Overview
Table 152. liferiver Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. liferiver Molecular Diagnostic Kits Product
Table 154. liferiver Recent Developments/Updates
Table 155. Leadman Corporation Information
Table 156. Leadman Description and Business Overview
Table 157. Leadman Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Leadman Molecular Diagnostic Kits Product
Table 159. Leadman Recent Developments/Updates
Table 160. Triplex Corporation Information
Table 161. Triplex Description and Business Overview
Table 162. Triplex Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Triplex Molecular Diagnostic Kits Product
Table 164. Triplex Recent Developments/Updates
Table 165. BGI Corporation Information
Table 166. BGI Description and Business Overview
Table 167. BGI Molecular Diagnostic Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. BGI Molecular Diagnostic Kits Product
Table 169. BGI Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Molecular Diagnostic Kits Distributors List
Table 173. Molecular Diagnostic Kits Customers List
Table 174. Molecular Diagnostic Kits Market Trends
Table 175. Molecular Diagnostic Kits Market Drivers
Table 176. Molecular Diagnostic Kits Market Challenges
Table 177. Molecular Diagnostic Kits Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Molecular Diagnostic Kits
Figure 2. Global Molecular Diagnostic Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Molecular Diagnostic Kits Market Share by Type in 2023 & 2030
Figure 4. PCR Product Picture
Figure 5. Gene Chip Product Picture
Figure 6. Fluorescence in Situ Hybridization Product Picture
Figure 7. DNA Sequencing Product Picture
Figure 8. Global Molecular Diagnostic Kits Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Molecular Diagnostic Kits Market Share by Application in 2023 & 2030
Figure 10. Infectious Disease Diagnosis
Figure 11. Genetic Diagnosis
Figure 12. Blood Screening
Figure 13. Other
Figure 14. Global Molecular Diagnostic Kits Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Molecular Diagnostic Kits Market Size (2019-2030) & (US$ Million)
Figure 16. Global Molecular Diagnostic Kits Sales (2019-2030) & (K Units)
Figure 17. Global Molecular Diagnostic Kits Average Price (US$/Unit) & (2019-2030)
Figure 18. Molecular Diagnostic Kits Report Years Considered
Figure 19. Molecular Diagnostic Kits Sales Share by Manufacturers in 2023
Figure 20. Global Molecular Diagnostic Kits Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Molecular Diagnostic Kits Players: Market Share by Revenue in 2023
Figure 22. Molecular Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Molecular Diagnostic Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Molecular Diagnostic Kits Sales Market Share by Country (2019-2030)
Figure 25. North America Molecular Diagnostic Kits Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Molecular Diagnostic Kits Sales Market Share by Country (2019-2030)
Figure 29. Europe Molecular Diagnostic Kits Revenue Market Share by Country (2019-2030)
Figure 30. Germany Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Molecular Diagnostic Kits Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Molecular Diagnostic Kits Revenue Market Share by Region (2019-2030)
Figure 37. China Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Molecular Diagnostic Kits Sales Market Share by Country (2019-2030)
Figure 48. Latin America Molecular Diagnostic Kits Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnostic Kits Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Molecular Diagnostic Kits Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Molecular Diagnostic Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Molecular Diagnostic Kits by Type (2019-2030)
Figure 58. Global Revenue Market Share of Molecular Diagnostic Kits by Type (2019-2030)
Figure 59. Global Molecular Diagnostic Kits Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Molecular Diagnostic Kits by Application (2019-2030)
Figure 61. Global Revenue Market Share of Molecular Diagnostic Kits by Application (2019-2030)
Figure 62. Global Molecular Diagnostic Kits Price (US$/Unit) by Application (2019-2030)
Figure 63. Molecular Diagnostic Kits Value Chain
Figure 64. Molecular Diagnostic Kits Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
